Novartis Reports Tumor Cases Linked to Zolgensma Gene Therapy
The drugmaker acknowledges nine tumor reports in children treated with the spinal muscular atrophy therapy, raising safety concerns for gene therapy researchers.
2 stories · RSS
The drugmaker acknowledges nine tumor reports in children treated with the spinal muscular atrophy therapy, raising safety concerns for gene therapy researchers.
State officials confirmed the infant's death, marking the first measles fatality in Wisconsin since 1990.
Required. We use your browser's storage to remember this choice, your light or dark
setting and the topics you follow, and a sign-in cookie (nm_reader) only if you make a call
on a market. None of it is used for tracking.
Accept all also lets Google Analytics set cookies (_ga, _ga_*)
so we can count visits and see which pages are read. With Accept required, Google
Analytics sets no cookies, though Google may still receive a basic page-view signal without them.